Studies module Sample Clauses

Studies module. No. Deliverable title Purpose Frequency When? Accessibility (Public or Recipient Confidential Information) (clause 26 (Confidentiality)) Content and delivery KS1 ARENA 15-minute Project survey [Drafting note: Delete this row where the Project is for a period of less than 6 months, as a survey is not required in this situation.] Efficient qualitative and quantitative data gathering. Anonymised data is used internally for ARENA’s quarterly portfolio updates. Quarterly From Commencement Date to the Final Milestone Date Recipient Confidential Information. ARENA and the Knowledge Sharing Agent (if applicable) only. ARENA to provide link to survey each quarter. KS2 ARENA-led event Attendance or participation in ARENA-led event (e.g. workshop, seminar or roundtable). Share Project information with other ARENA funded Projects and/or key stakeholders. Minimum one per year, as agreed with ARENA. From Commencement Date to the Final Milestone Date Public, or as agreed by the parties Recipient to provide documentation (i.e., slides, word document, pdf etc) to ARENA following attendance, to contain sufficient information to be read as a standalone document. KS3 Industry-led event Attendance and participation at industry-led event. Project exposure, knowledge dissemination at an industry-led event. Once only From Commencement Date to the Final Milestone Date Public, or as agreed by the parties Evidence of active involvement to be provided (e.g., presentation slides, recordings, written event summary), or as agreed with ARENA. KS4 Final public study report Share findings with the market Once only Final Milestone Date Public Report must comply with the standards outlined in item 4.5 (Knowledge Sharing Deliverables) of Schedule 1 (The Project). ▇▇▇▇▇ may request a briefing session to share and discuss the findings of the project, and the draft version of the report.
View SourceView Similar (3)
Studies module. Deliverable title Purpose Frequency When? Accessibility (Public or Recipient Confidential Information) (clause 22) Content and delivery
View SourceView Similar (2)
Studies module. What? Why? Frequency? When? Who is it for? How? (expected content and delivery)
View Source
Studies module. No. Deliverable title Purpose Frequency When? Accessibility (Public or Recipient Confidential Information) (clause 26) Content and delivery KS1 ARENA 15-minute Project Survey Efficient qualitative and quantitative data gathering. 10 days from the end of each quarter From Commencement Date to 12 months following the Final Milestone Date ARENA and the Knowledge Sharing Agent only. ARENA to provide link to survey at Commencement Date KS2 Lessons learnt report Public information readily accessible, useable and searchable. Project specific lessons learnt 2 times per year From Commencement Date [or the later of the Commencement Date or Financial Close] to Final Milestone Date Public Suggested topics are lessons on: project objectives; Stakeholder acceptance/change management; technical, regulatory, financial/ economic, social/ consumer; implications for industry and next steps. Insights into resale values Financing decisions Securing external finance (if applicable) Insights into Total Cost of Ownership (TCO) KS3 Infrastructure Design report This report will detail the findings and insights gathered by the Recipient during the construction and commissioning phases of the Project. The public report will share knowledge in an aim to improve the understanding of design and delivery requirements for the implementation of an EV fleet. Once At the applicable Milestone, as required by ARENA Public Summarise the key considerations in the design and implementation of infrastructure required to accommodate the electric fleet. This can include: Site design changes/upgrades/additions Changes to electricity infrastructure at main charging sites Procurement and installation of charging infrastructure Other software/hardware upgrades Grid integration considerations KS4 Change Management report This report will summarise the Recipient’s experience with managing the transition to an EV fleet. Once At the applicable Milestone, as required by ARENA Public Summarise the key finding and experience of changing the composition of the fleet to EV. This can include: How well did the Change Management plan work in practice Unanticipated challenges Unanticipated benefits and positive experiences driver behaviours alleviating anxieties about the unknown KS5 Public Project Knowledge Sharing Report Public version of Final Report that includes, at a minimum; executive summary, Project overview, findings / outcomes including issues referenced in the application, lessons learned, why the Projec...
View Source

Related to Studies module

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK

  • Technology Upgrades Notwithstanding any other provision of this Agreement, Verizon shall have the right to deploy, upgrade, migrate and maintain its network at its discretion. The Parties acknowledge that Verizon, at its election, may deploy fiber throughout its network and that such fiber deployment may inhibit or facilitate Covista’s ability to provide service using certain technologies. Nothing in this Agreement shall limit Verizon's ability to modify its network through the incorporation of new equipment or software or otherwise. Covista shall be solely responsible for the cost and activities associated with accommodating such changes in its own network.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in ▇▇▇▇ rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Protocols Each party hereby agrees that the inclusion of additional protocols may be required to make this Agreement specific. All such protocols shall be negotiated, determined and agreed upon by both parties hereto.